Organ replacement may delay aging but will not deliver immortality

Repeated organ transplants are not a realistic path to immortality; researchers at a conference on aging point to deep scientific unknowns, surgical risks, and shortages of donor organs that limit replacement therapies.

I attended a conference on aging in Manchester where scientists presented incremental, molecular studies of aging. That careful work contrasted with remarks reportedly exchanged between China’s Xi Jinping and Russia’s Vladimir Putin, both 72, in which Xi described people at 70 as still young and Putin suggested that continuous organ transplantation could let people live younger and even achieve immortality. The article frames that claim as a simplistic view of aging and sets out to examine whether repeated organ replacement could plausibly extend human life dramatically.

Aging remains poorly defined and poorly understood, and researchers do not agree on its causes. Organ transplantation has been a medical tool since the 1950s and has saved many lives, but it is not a simple route to longer life. Donor organs are scarce and thousands die on waiting lists. Transplantation requires major surgery and typically lifelong immunosuppression, which raises the risk of infections and some cancers. Jesse Poganik, who studies aging at Brigham and Women’s Hospital, cautions that repeated surgeries carry real risks; he recounts that his 24-year-old cousin developed a form of cancer after a liver and heart transplant and died weeks later.

Researchers are nonetheless developing biological and synthetic replacement options, from stem cell injections to seeding scaffolds. Early successes include a 1999 trial in which volunteers’ cells were used to grow bladder-shaped collagen scaffolds that were transplanted into seven people. Scientists such as Jean Hébert are exploring more ambitious steps, including replacing parts of mice brains with embryonic stem cells, while other teams test longevity drugs in model organisms such as C. elegans, with modest translation rates to mice. Some researchers, including Sierra Lore, argue replacement is an attractive avenue because it may not require complete understanding of molecular aging. The article concludes that replacement therapies have potential but that the idea of continuous organ swapping as a route to immortality is not supported by current science or practical realities.

65

Impact Score

OpenClaw pushes autonomous Artificial Intelligence agents into enterprises

OpenClaw’s rapid growth is accelerating interest in persistent, self-hosted autonomous agents that run continuously instead of waiting for prompts. NVIDIA is positioning NemoClaw as a more secure reference implementation for organizations that want local control, auditability and hardened deployment defaults.

Indiana launches Artificial Intelligence business portal

Indiana is rolling out IN AI, a statewide portal meant to help employers adopt Artificial Intelligence with practical guidance, workshops and peer support. State leaders and business groups are positioning the effort as a way to raise productivity, wages and job growth while keeping workers at the center.

Goodfire launches model debugging tool for large language models

Goodfire has introduced Silico, a mechanistic interpretability platform designed to let developers inspect and adjust model behavior during development. The company is positioning it as a way to give smaller teams deeper control over open-source models and more trustworthy outputs.

Nvidia launches nemotron 3 nano omni for enterprise agents

Nvidia has introduced Nemotron 3 Nano Omni, a multimodal open model designed to support enterprise agents that reason across vision, speech and language. The launch extends Nvidia’s push beyond hardware into models and services while targeting more efficient agentic workflows.

Intel 18A-P node improves performance and efficiency

Intel plans to present new results for its 18A-P process at the VLSI 2026 Symposium, highlighting gains in performance, power efficiency, and manufacturing predictability. The updated node is positioned as a stronger option for customers seeking 18A density with better operating characteristics.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.